| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/31/2004 | CN1143855C I (ortho)-anthranilamide derivatives as anti-coagulants |
| 03/30/2004 | US6713603 Adjusted nucleotide sequences for use as antisense tools in genetic engineering |
| 03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 03/30/2004 | CA2130755C Intermediates useful in the preparation of purine nucleoside analogues |
| 03/25/2004 | WO2004024743A1 Crystal of 2-amino-6-(4-methoxyphenylthio)-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester |
| 03/25/2004 | WO2003037860A3 Purine analogs having hsp90-inhibiting activity |
| 03/25/2004 | WO2003022214A3 Piperazine and homopiperazine compounds |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058893 Sexual disorders, aids, hepatitis virus |
| 03/24/2004 | EP1399446A1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| 03/24/2004 | EP1292606A4 Positively-charged peptide nucleic acid analogs with improved properties |
| 03/24/2004 | EP1196416B1 Substituted purine derivatives as inhibitors of cell adhesion |
| 03/23/2004 | US6710782 Data driven layout engine |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/18/2004 | WO2004022541A1 1,4-substituted cyclohexane derivatives |
| 03/18/2004 | WO2004021979A2 PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS |
| 03/18/2004 | WO2003035009A3 Treatment of acute myeloid leukemia with indolinone compounds |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040053853 Topiramate salts and compositions comprising and methods of making and using the same |
| 03/18/2004 | US20040053815 Inactivating a nuclear localization signal of a protein by contacting the protein with a compound that binds reversibly; parasiticides; viricides |
| 03/17/2004 | EP1397142A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 03/17/2004 | EP0731807B1 N-2 substituted purines |
| 03/17/2004 | CN1483043A Chitosan-containing multicomponent composition and process for preparing the same |
| 03/11/2004 | WO2004020441A1 Hetereoaryl nitrile derivatives |
| 03/11/2004 | WO2004019949A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | WO2002076404A3 Fatty alcohol drug conjugates |
| 03/11/2004 | CA2496920A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 03/11/2004 | CA2494931A1 Hetereoaryl nitrile derivatives |
| 03/10/2004 | CN1141305C Manufacture of 1, 3-oxathiolane nucleosides |
| 03/09/2004 | US6703394 Viricides such as (r)-9-(2-(stearoyloxymethyl)-4-(l-valyloxy) butyl)guanine for treatment of hiv; bioavailability |
| 03/04/2004 | WO2004018470A2 Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 03/04/2004 | WO2004018469A1 Novel purine derivatives, production and use thereof as medicaments |
| 03/04/2004 | WO2004018468A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 03/04/2004 | WO2004018467A2 Phenacyl xanthine derivatives as dpp-iv inhibitor |
| 03/04/2004 | WO2004002990A3 Synthesis of purine derivatives |
| 03/04/2004 | WO2003042214A3 A2b adenosine receptor antagonists |
| 03/04/2004 | DE10238477A1 Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel New purine derivatives, their preparation and their use as medicaments |
| 03/04/2004 | DE10238470A1 Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel New xanthine derivatives, their preparation and their use as medicaments |
| 03/04/2004 | DE10238243A1 New 8-(3-amino-piperidin-1-yl)-xanthine derivatives are dipeptidylpeptidase-IV inhibitors useful for, e.g. treating diabetes mellitus, arthritis or obesity |
| 03/04/2004 | CA2496684A1 Crystalline solid famciclovir forms i, ii, iii and preparation thereof |
| 03/04/2004 | CA2496325A1 Phenacyl xanthine derivatives as dpp-iv inhibitor |
| 03/04/2004 | CA2496211A1 New purine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 03/03/2004 | EP1394163A1 Bicycloamide derivatives |
| 03/03/2004 | EP1392690A2 Novel processes for the preparation of adenosine compounds and intermediates thereto |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | CN1140527C Phenyl xanthine ester and amide derivatives |
| 03/03/2004 | CN1140269C Bicyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |
| 03/03/2004 | CA2438909A1 1,4-substituted cyclohexane derivatives |
| 03/03/2004 | CA2400996A1 1,4-substituted cyclohexane derivatives |
| 03/02/2004 | US6699840 Controlled- or delayed-release forms of topiramate |
| 03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
| 02/26/2004 | WO2004016613A2 Purine derivatives and their use as antiproliferative agents |
| 02/26/2004 | WO2004016612A2 New purine derivatives |
| 02/26/2004 | WO2003040144A3 Heterocyclic compound based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 02/26/2004 | US20040038996 8-Quinolinxanthine and 8-isoquinolinxant hine derivatives as PDE 5 inhibitors |
| 02/26/2004 | US20040038994 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1390368A1 Disubstituted 7,9-guaninium halides as telomerase inhibitors |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
| 02/25/2004 | EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants |
| 02/25/2004 | EP0758897B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | CA2241887C Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine |
| 02/19/2004 | WO2004015116A1 Thermolabile caffeine fraction of tea leaves and use of this fraction in an efficient method of introducing agrobacterium-mediated genetic transformation in plants |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014913A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2004014912A1 Improved synthesis for hydroxyalkylated heterocyclic bases |
| 02/19/2004 | WO2004014911A1 Phosphodiesterase 4 inhibitors |
| 02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 02/19/2004 | US20040034224 Synthesis of purine derivatives |
| 02/19/2004 | US20040034043 Positively-charged peptide nucleic acid analogs with improved properties |
| 02/19/2004 | US20040034020 A purine deriveative, useful for treatment of inflammatory conditions, immune disorders, tissue injury, infections, and cancer |
| 02/19/2004 | US20040034014 3,7-dihydro-purine-2,6-dione derivatives useful for treating obesity and type II diabetes |
| 02/19/2004 | CA2494028A1 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 02/19/2004 | CA2494026A1 Phosphodiesterase 4 inhibitors |
| 02/18/2004 | EP1104422B1 Phenyl xanthine derivatives |
| 02/18/2004 | EP0983271B1 Carbocyclic nucleoside hemisulfate and its use in treating viral infections |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1138545C Use of penciclovir for treatment of human herpes-virus-8 |
| 02/17/2004 | US6693106 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's) |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693104 Theobromine with an anti-carcinogenic activity |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | CA2494421A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/11/2004 | EP1387819A2 Hydrogenation processes performed in ionic liquids |
| 02/11/2004 | CN1137892C Preparation of N-9 substituted guanine compound |
| 02/10/2004 | US6689884 Supramolecular pairing system, its preparation and use |
| 02/05/2004 | US20040024214 Such as (R)-9-(2-(stearoyloxymethyl)-4-(L-valyloxy)butyl)-guanine for treatment of herpes and retroviral infections |
| 02/05/2004 | US20040023994 Thiopurine having a sulfur heteroatom conjugated to an alpha-, beta-unsaturated carbonyl moiety and a pharmaceutical carrier |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/04/2004 | EP1386923A1 Novel adenine derivatives |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1385831A2 Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1137100C Tricyclic compounds capable of inhibiting tyrosine kinases of epidermal growth factor receptor family |